Inventor
MCGREW JEFFREY T
US19 patents
⚠️ This page may combine multiple inventors who share the name “MCGREW JEFFREY T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNEX CORP
11 patentsUS5962406AOct 5, 1999
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
IMMUNEX CORP96 citations97
US6974681B1Dec 13, 2005
Cell culture performance with vanadate
IMMUNEX CORP63 citations96
US6410711B1Jun 25, 2002
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP64 citations96
US5981724ANov 9, 1999
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP65 citations96
US6872549B2Mar 29, 2005
Methods for increasing polypeptide production
IMMUNEX CORP71 citations94
US6291661B1Sep 18, 2001
flt3-L mutants and method of use
IMMUNEX CORP47 citations94
US6632637B1Oct 14, 2003
Vectors and methods for recombinant protein expression
IMMUNEX CORP26 citations92
US7067118B2Jun 27, 2006
Methods of using mutant flt3-ligand polypeptides to induce cellular expansion
IMMUNEX CORP6 citations71
US7452695B2Nov 18, 2008
Methods for increasing polypeptide production
IMMUNEX CORP7 citations70
US7691605B2Apr 6, 2010
Selection of cells expressing heteromeric polypeptides
IMMUNEX CORP3 citations56
US7968313B2Jun 28, 2011
Selection of cells expressing heteromeric polypeptides
IMMUNEX CORP0 citations46
JUST EVOTEC BIOLOGICS INC
5 patentsUS11261462B2Mar 1, 2022
Inducible expression from transposon-based vectors and uses
JUST EVOTEC BIOLOGICS INC4 citations69
US11098310B2Aug 24, 2021
Expression from transposon-based vectors and uses
JUST EVOTEC BIOLOGICS INC5 citations69
US11028410B2Jun 8, 2021
Hybrid promoter and uses thereof
JUST EVOTEC BIOLOGICS INC6 citations69
US11692193B2Jul 4, 2023
Expression from transposon-based vectors and uses
JUST EVOTEC BIOLOGICS INC1 citations59
US11685933B2Jun 27, 2023
Inducible expression from transposon-based vectors and uses
JUST EVOTEC BIOLOGICS INC1 citations59